Correlation between pulmonary outcomes and nutritional status following treatment with elexacaftor/tezacaftor/ivacaftor in people with Cystic fibrosis
{{output}}
Background: Elexacaftor/tezacaftor/ivacaftor (ETI) improves lung function and nutritional status in people with cystic fibrosis (pwCF); it is unclear whether these responses are correlated, and whether pancreatic status modifies ... ...
